Theanine Effects on Sedative and Hypnosis Induced by Pentobarbital Sodium In ICR Mice

YU Xi-chong; WU Bo-la; ZHU Tong-jun; YANG Wei

doi:10.13305/j.cnki.jts.2009.4.002

PDF(274 KB)

Journal of Tea Science ›› 2009, Vol. 29 ›› Issue (4) : 257-262. DOI: 10.13305/j.cnki.jts.2009.4.002

Theanine Effects on Sedative and Hypnosis Induced by Pentobarbital Sodium In ICR Mice

YU Xi-chong¹, WU Bo-la¹, ZHU Tong-jun¹, YANG Wei^2,*

Author information +

History +

Abstract

In the present study, the locomotor activities and disappearance of righting reflex on ICR mice were employed to evaluate effects of theanine on the sedative and hypnosis induced by pentobarbital sodium. Results showed that theanine alone decreased locomotor activity in dose-dependent manner and had no stimulant effect, 50% inhibition dose of locomotor activity was 0.8518 g/kg, low doses of theanine(≤1.0 g/kg) enhanced inhibition effect of locomotor activity induced by pentobarbital sodium(5 mg/kg), however, high dose (2.0 g/kg) of theanine reversed the inhibition, meanwhile, theanine enhanced hypnosis induced by pentobarbital sodium(25 mg/kg) in dose-dependent manner. It is concluded that theanine changed locomotor activity of mice induced by low dose of pentobarbital sodium(5 mg/kg) in dimensional change (“U” shape style), but not higher dose of pentobarbital sodium(25 mg/kg).

Key words

hypnosis / pentobarbital / sedation / theanine

Cite this article

EndNote

Ris (Procite)

Bibtex

Download Citations

YU Xi-chong, WU Bo-la, ZHU Tong-jun, YANG Wei. Theanine Effects on Sedative and Hypnosis Induced by Pentobarbital Sodium In ICR Mice[J]. Journal of Tea Science. 2009, 29(4): 257-262 https://doi.org/10.13305/j.cnki.jts.2009.4.002

References

[1] 吕毅, 郭雯飞, 倪捷儿, 等. 茶氨酸的生理作用及合成[J]. 茶叶科学, 2003, 23(1): 1~5.
[2] Egashira N, Hayakawa K, Mishima K, et al. Neuroprotective effect of gamma-glutamylethylamide (theanine) on cerebral infarction in mice[J]. Neurosci Lett, 2004, 363(1): 58~61.
[3] Kakuda T, Yanase H, Utsunomiya K, et al. Protective effect of gamma-glutamylethylamide (theanine) on ischemic delayed neuronal death in gerbils[J]. Neurosci Lett, 2000, 289(3): 189~192.
[4] Nagasawa K, Aoki H, Yasuda E, et al. Possible involvement of group I mGluRs in neuroprotective effect of theanine[J]. Biochem Biophys Res Commun, 2004, 320(1): 116~122.
[5] Kakuda T, Nozawa A, Unno T, et al. Inhibiting effects of theanine on caffeine stimulation evaluated by EEG in the rats[J]. Biosci Biotech. Biochem, 2000, 64(2): 287~293.
[6] 王小雪, 邱隽, 宋宇, 等. 茶氨酸的抗疲劳作用研究[J]. 中国公共卫生, 2002, 18(3): 315~317.
[7] Taverna FA, Cameron BR, Wang LY, et al. Sensitivity of AMPA receptors to pentobarbital[J]. Eur J Pharmacol, 1994, 267(3): R3~5.
[8] Yamakura T, Sakimura K, Mishina M, et al. The sensitivity of AMPA-selective glutamate receptor channels to pentobarbital is determined by a single amino acid residue of the alpha 2 subunit[J]. FEBS-Lett, 1995, 374(3): 412~414.
[9] Kakuda T, Nozawa A, Sugimoto A, et al. Inhibition by theanine of binding of [3H]-AMPA, [3H]-kainite, and [3H]-MDL105519 to glutamate receptors[J]. Biosci Biotechnol Biochem, 2002, 66(12): 2683~2686.
[10] Menniti FS, Buchan AM, Chenard BL, et al. CP-465,022, a selective noncompetitive AMPA receptor antagonist, blocks AMPA receptors but is not neuroprotective in vivo[J]. Stroke, 2003, 34: 171~176.
[11] Imre G, Fokkema DS, Den Boer JA, et al. Dose-response characteristics of ketamine effect on locomotion, cognitive function and central neuronal Activity[J]. Brain Research Bull, 2006, 69: 338~345.
[12] Jentsch JD, Roth RH.The neuropsychopharmacology of phencyclidine: from NMDA receptor hypofunction to the dopamine hypothesis of schizophrenia[J]. Neuropsychopharmacology, 1999, 20(3): 201~225.
[13] yokogoshi H, kobayashi M, et al. Effect of theanine, r-glutamylethylamide, on brain monoamines and striatal dopamine release in conscious rats[J]. Neurochem Res, 1998, 23(5): 667~673.